Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -99.00% | -.--% | -.--% |
04-12 | North American Morning Briefing : Big Banks Kick -2- | DJ |
03-21 | North American Morning Briefing : Investors -2- | DJ |
Business Summary
Number of employees: 125
Sales per Business
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical Products
100.0
%
| 18 | 100.0 % | 50 | 100.0 % | +184.10% |
Sales per region
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 18 | 100.0 % | 50 | 100.0 % | +184.10% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Sergio Alegre
CMP | Compliance Officer | - | 31/07/16 |
James Schaub
COO | Chief Operating Officer | 42 | 31/12/15 |
Michael Depetris
AUD | Comptroller/Controller/Auditor | - | 17/04/22 |
Jarret Miller
HRO | Human Resources Officer | - | 31/12/15 |
General Counsel | 60 | 30/11/13 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Gregory Cowan
BRD | Director/Board Member | 70 | 31/12/18 |
Alisa Lask
BRD | Director/Board Member | 53 | 09/08/22 |
Michael DeBiasi
BRD | Director/Board Member | 48 | 30/09/19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 111,406,043 | 107,306,425 ( 96.32 %) | 0 | 96.32 % |
Company contact information
RVL Pharmaceuticals Plc
400 Crossing Boulevard
08807, Bridgewater
+908 809 1300
http://www.rvlpharma.comSector
1st Jan change | Capi. | |
---|---|---|
-.--% | 111 | |
-4.24% | 86.85B | |
+2.76% | 40.16B | |
-16.98% | 31.28B | |
+57.86% | 25.27B | |
-16.24% | 15.33B | |
-9.12% | 11.96B | |
-42.56% | 11.61B | |
-17.10% | 11.69B | |
+6.89% | 8.83B |
- Stock Market
- Equities
- RVLPQ Stock
- Company RVL Pharmaceuticals plc